Cyclohexane

Cyclohexane

SCHEMBL663994

C(OCC1CO1)C1CO1.C1CCCCC1.CO.CO

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.54
MAPK1 P28482 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 9/20 0.48
TDP1 Q9NUW8 3/20 0.48
TP53 P04637 4/20 0.42
CYP3A4 P08684 2/20 0.42
GLA P06280 1/20 0.36
HIF1A Q16665 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
KMT2A Q03164 1/20 0.34
PPARG P37231 1/20 0.34
CHRM2 P08172 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
PDK1 Q15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL2554783 1.00 TSHR (0.54) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
Cyclohexane SCHEMBL17941724 1.00 TSHR (0.54) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
Methyl Alcohol SCHEMBL3660410 1.00 TSHR (0.54) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
Methyl Alcohol SCHEMBL6913269 0.95 TSHR (0.59) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
SCHEMBL8044179 0.92 TSHR (0.62) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
Cyclopropane SCHEMBL963062 0.92 TSHR (0.62) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
SCHEMBL961313 0.92 TSHR (0.62) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
Cyclohexane SCHEMBL960269 0.92 TSHR (0.62) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
SCHEMBL28515263 0.92 TSHR (0.62) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1
Methoxymethane SCHEMBL20526029 0.90 TSHR (0.54) TSHRMAPK1SMN1; SMN2ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735503-A1 HEAT-CURABLE SEALING COMPOSITION Sika Technology AG (CH) 2026-05-06 EP claimed
EP-3873996-B1 LABELS HEWLETT PACKARD DEVELOPMENT CO (US) 2026-03-11 EP claimed
US-20260035607-A1 Well Barriers For Subterranean Storage Of Carbon Dioxide HALLIBURTON ENERGY SERVICES, INC. (US) 2026-02-05 US claimed
US-12448559-B1 Puddle job with delayed setting of resin via a polymerization reaction with an activator HALLIBURTON ENERGY SERVICES, INC. (US) 2025-10-21 US claimed
EP-4584326-A1 CURABLE POLYMER COMPOSITION HAVING IMPROVED WASH-OFF RESISTANCE Zephyros Inc. (US) 2025-07-16 EP claimed
CN-120118480-A Degradable epoxy resin composite material with adjustable curing speed and preparation and moderate full recycling methods thereof 哈尔滨工业大学 2025-06-10 CN claimed
US-12319867-B2 Accelerating agents for resin cement composite systems for oil well cementing HALLIBURTON ENERGY SERVICES, INC. (US) 2025-06-03 US claimed
CN-120082215-A Modified asphalt material and preparation method and application thereof 余秋琼 2025-06-03 CN claimed
WO-2025073846-A1 HEAT-CURING EPOXY RESIN COMPOSITION SUITABLE FOR LOW CURING TEMPERATURE WITH GOOD OPEN TIME AND CORROSION RESISTANCE SIKA TECHNOLOGY AG (CH) 2025-04-10 WO claimed
EP-4534580-A1 HEAT-CURING EPOXY RESIN COMPOSITION SUITABLE FOR LOW CURING TEMPERATURE WITH GOOD OPEN TIME AND CORROSION RESISTANCE Sika Technology AG (CH) 2025-04-09 EP claimed
CN-1930345-A Materials useful in making cellulosic capture fibers in sheet form RAYONIER PROD & FNCL SERV CO (US) 2007-03-14 CN claimed
CN-1916004-A Organic-inorganic metal hybrid material and composition comprising the same SAMSUNG ELECTRONICS CO LTD (KR) 2007-02-21 CN claimed
EP-1470181-B1 IMPROVED INTERFACE ADHESIVE LORD CORP (US) 2005-08-24 EP claimed
US-20040229768-A1 Low surface tension surfactants based on amino alcohol and their use EVONIK DEGUSSA GMBH (DE) 2004-11-18 US claimed
EP-1470181-A1 IMPROVED INTERFACE ADHESIVE Lord Corporation (US) 2004-10-27 EP claimed
WO-2004003066-A1 IMPROVED INTERFACE ADHESIVE LORD CORPORATION (US) 2004-01-08 WO claimed
US-20040000712-A1 Interface adhesive LORD CORPORATION 2004-01-01 US claimed
US-20020105093-A1 Encapsulant composition and electronic package utilizing same INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2002-08-08 US claimed
US-5587409-A Curing agents for aqueous epoxy resin dispersions HOECHST AKTIENGESELLSCHAFT (DE) 1996-12-24 US claimed
EP-0590975-A1 Low viscosity and solvent-free one-component type epoxy resin adhesive composition W.R. Grace & Co.-Conn. (US) 1994-04-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035607-A1 Well Barriers For Subterranean Storage Of Carbon Dioxide PUF60, CPS1, SLC14A1 TSHR 3033/4885MAPK1 3597/4885SMN1; SMN2 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.